Neurology Clinical Trials

Statistical methods in neurology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All neurology trials

816 results

• ADORE BRAINIndependent statistical analysis of Brain Health in Midlife: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06640842).Phase NAResults postedn = 24NCT06640842
• Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): Complete Statistical AnalysisIndependent statistical analysis of Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01764711).Phase NAResults postedn = 13NCT01764711
• ADVANCEIndependent statistical analysis of the ADVANCE phase 3 trial of blood pressure and glucose lowering for prevention of vascular disease in high-risk patients with type 2 diabetes, including its factorial design, composite…Phase 3n = 11,140NCT00145925
• ADVANCEIndependent statistical analysis of the phase 3 ADVANCE trial of peginterferon beta-1a versus placebo in relapsing multiple sclerosis, covering negative binomial rate ratios for annualized relapse rate, Cox hazard ratios, lesion mean…Phase 3Results postedn = 1,516NCT00906399
• AEROBICIndependent statistical analysis of Acute Exercise and the Cerebral Metabolic Response in Aging and Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 60NCT04299308
• Aging and Estrogen on Cortical Function: Complete Statistical AnalysisIndependent statistical analysis of Aging and Estrogen on Cortical Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01268046).Phase 1/2Results postedn = 38NCT01268046
• ALDERIndependent statistical analysis of Anxiety Lowering and Deprescribing Through Emotion Regulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06359314).Phase NAResults postedn = 33NCT06359314
• ALFSG-MBTIndependent statistical analysis of 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2/3Results postedn = 76NCT02786836
• ALIASIndependent statistical analysis of ALIAS, a randomized phase 3 trial of albumin versus saline in acute ischemic stroke, including trial design, endpoints, logistic regression, risk ratios, nonparametric analysis, safety, and interpretation.Phase 3Results postedn = 841NCT00235495
• ALIGN: Aligning Medications With What Matters Most (Demonstration): Complete Statistical AnalysisIndependent statistical analysis of ALIGN: Aligning Medications With What Matters Most (Demonstration): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06335953).Phase NAResults postedn = 474NCT06335953
• ALLAY-LID-IIndependent statistical analysis of Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 87NCT02153645
• Altering Activation Patterns Post-stroke: Complete Statistical AnalysisIndependent statistical analysis of Altering Activation Patterns Post-stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02418949).Phase NAResults postedn = 96NCT02418949
• AltoidaMLIndependent statistical analysis of Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 548NCT02843529
• AMADIndependent statistical analysis of Efficacy of Acupuncture in Macular Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02255981).Phase NAResults postedn = 33NCT02255981
• Amara View Benchmark Study: Complete Statistical AnalysisIndependent statistical analysis of Amara View Benchmark Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06535932).Phase NAResults postedn = 35NCT06535932
• AMARANTHComplete statistical analysis of the AMARANTH phase 2/3 trial of lanabecestat in early Alzheimer's disease, including trial design, primary and secondary endpoint results, ANCOVA and mixed-effects methodology, safety, and statistical interpretation.Phase 2/3Results postedn = 2,218NCT02245737
• AMAZEIndependent statistical analysis of Cohort 2 (Abdominoplasty) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06109428).Phase 4Results postedn = 37NCT06109428
• AMPACT1Independent statistical analysis of AM-101 in the Treatment of Post-Acute Tinnitus 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01934010).Phase 3Results postedn = 260NCT01934010
• An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment: Complete Statistical AnalysisIndependent statistical analysis of An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1Results postedn = 60NCT05051644
• An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 58NCT04201262
• An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics: primary endpoint results, effect estimate with confidence interval,…Phase 4Results postedn = 103NCT01060124
• An Efficacy and Tolerability Study of Topiramate in Participants With Migraine: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Tolerability Study of Topiramate in Participants With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 250NCT01060111
• An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: Complete Statistical AnalysisIndependent statistical analysis of An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 158NCT04851691
• An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 257NCT00745615
• An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS: Complete Statistical AnalysisIndependent statistical analysis of An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS: primary endpoint results, effect estimate with confidence…Phase 4Results postedn = 24NCT02087748
• An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 641NCT01686581
• An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 73NCT01063764
• An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 7NCT02427607
• An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 104NCT01202227
• An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): Complete Statistical AnalysisIndependent statistical analysis of An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): primary endpoint results, effect estimate with…Phase 4Results postedn = 78NCT01806298
• An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites: primary endpoint results, effect estimate with confidence…Phase 1Results postedn = 6NCT02169427
• An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge): Complete Statistical AnalysisIndependent statistical analysis of An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 47NCT03789656
• Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease: Complete Statistical AnalysisIndependent statistical analysis of Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00069329).Phase 1/2Results postedn = 43NCT00069329
• Analysis of Electrocorticographic Signals: Complete Statistical AnalysisIndependent statistical analysis of Analysis of Electrocorticographic Signals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03785028).Phase NAResults postedn = 5NCT03785028
• Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients: Complete Statistical AnalysisIndependent statistical analysis of Analysis of Snore Sound Following Minimal Invasive Surgery in Sleep-disordered Breathing Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 30NCT01955083
• Anesthesia and Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Anesthesia and Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00232817).Phase 4Results postedn = 23NCT00232817
• ANGEL-ASPECTIndependent statistical analysis of ANGEL-ASPECT, a randomized trial of endovascular therapy versus best medical management in acute ischemic stroke patients with large infarct core.Phase NAn = 456NCT04551664
• ANSWERIndependent statistical analysis of Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312856).Phase NAResults postedn = 34NCT02312856
• Anti-Diabetic Medications to Fight PD and LBD: Complete Statistical AnalysisIndependent statistical analysis of Anti-Diabetic Medications to Fight PD and LBD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06263673).Phase 4Results postedn = 18NCT06263673
• Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26: Complete Statistical AnalysisIndependent statistical analysis of Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 181NCT00700713
• Antineoplaston Therapy in Treating Patients With Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003483).Phase 2Results postedn = 3NCT00003483
• APEX 241Independent statistical analysis of Aripiprazole Open-Label, Safety and Tolerability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00102518).Phase 3Results postedn = 325NCT00102518
• Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02889562).Phase 2/3Results postedn = 56NCT02889562
• APMIndependent statistical analysis of APM in the Evoke SCS System to Program Patients With Chronic Pain of the Trunk and/or Limbs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 30NCT06057480
• Application of Ideal Binary Masking to Disordered Speech: Complete Statistical AnalysisIndependent statistical analysis of Application of Ideal Binary Masking to Disordered Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05244603).Phase NAResults postedn = 435NCT05244603
• Approach to Sexuality From Occupational Therapy in People With Acquired Brain Injury in Subacute Stage: Complete Statistical AnalysisIndependent statistical analysis of Approach to Sexuality From Occupational Therapy in People With Acquired Brain Injury in Subacute Stage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 12NCT03911752
• ARDAIndependent statistical analysis of A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy: primary endpoint…Phase 2Results postedn = 54NCT05225675
• ARESTIndependent statistical analysis of Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 91NCT02283294
• Arimoclomol in Amyotropic Lateral Sclerosis – Open Label Extension Trial: Complete Statistical AnalysisIndependent statistical analysis of Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03836716).Phase 3Results postedn = 120NCT03836716
• Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 67NCT02478580

← All therapeutic areas